Episode 47
Treatment of Resistant Pseudomonas Aeruginosa Infections (AAC ed.)
Editors in Conversation · Cesar Arias, Michael Satlin, Alessandra Carattoli
May 14, 202252m 18s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Infections caused by multidrug-resistant Pseudomonas aeruginosa are considered a major public health problem. Antibiotic options are scarce but new drugs are emerging and more maybe available in the near future.
Topics discussed:- Pseudomonas aeruginosa as an important pathogen capable of developing resistance to multiple antibiotics
- Common mechanisms of resistance in Pseudomonas aeruginosa
- The current and future approaches for these MDR organisms.
- Michael Satlin, MD, Associate Professor of Medicine, Pathology and Laboratory Medicine, William Randolph Hearst Foundation Clinical Scholar in Microbiology and Infectious Diseases at Weill Cornell Medical College, New York, NY
- Alessandra Carattoli, PhD, Professor of Microbiology at the Sapienza University of Rome, Italy. Editor, AAC
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.